Preface |
|
ix | |
|
|
1 | (16) |
|
Stents Currently Available |
|
|
17 | (70) |
|
|
20 | (3) |
|
|
20 | (3) |
|
|
23 | (30) |
|
Palmaz-Schatz Stents (PS-153™, Spiral™ and Crown™) |
|
|
23 | (3) |
|
ACS MULTI-LINK™, ACS MULTI-LINK RX DUET™` |
|
|
26 | (2) |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
30 | (1) |
|
IRIS II™, SPIRAL FORCE™ and ZEBRA™ |
|
|
30 | (3) |
|
|
33 | (1) |
|
JOSTENT™ Plus, JOSTEN™ Flex |
|
|
34 | (2) |
|
|
36 | (1) |
|
PURA-A™, PURA-VARIO™, PURA-VARIO-A™ and PURA-VARIO-Al™ |
|
|
36 | (2) |
|
|
38 | (2) |
|
|
40 | (1) |
|
|
40 | (2) |
|
Parallel-Serial-Jang™ (PSJ-3) |
|
|
42 | (1) |
|
InFlow-Stent™, InFlow-Gold-Stent™ |
|
|
43 | (1) |
|
|
43 | (3) |
|
|
46 | (1) |
|
CIA (Coronary Improved Architecture) |
|
|
47 | (1) |
|
Diamond AS™, Diamond Flex AS™ |
|
|
47 | (2) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
50 | (2) |
|
Medtronic Self-Expanding Nitinol Stent |
|
|
52 | (1) |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
53 | (6) |
|
|
53 | (2) |
|
|
55 | (2) |
|
|
57 | (1) |
|
Freedom™ and Freedom Force™ |
|
|
58 | (1) |
|
|
58 | (1) |
|
|
59 | (3) |
|
AVE Micro Stent II™ and GFX™ |
|
|
59 | (2) |
|
|
61 | (1) |
|
|
62 | (3) |
|
|
62 | (1) |
|
|
63 | (2) |
|
|
65 | (22) |
|
Randomized Clinical Trials |
|
|
87 | (52) |
|
Stenting compared with PTCA |
|
|
87 | (16) |
|
Native Vessel de-novo stenoses |
|
|
87 | (7) |
|
Saphenous vein graft disease |
|
|
94 | (1) |
|
|
94 | (1) |
|
|
95 | (3) |
|
Acute or threatened closure after PTCA |
|
|
98 | (1) |
|
Stenting in acute myocardial infarction |
|
|
99 | (3) |
|
Stenting compared with directional atherectomy |
|
|
102 | (1) |
|
Evaluation of adjunctive therapy |
|
|
103 | (36) |
|
Adjunctive pharmacotherapy |
|
|
103 | (1) |
|
Acute and subacute thrombosis |
|
|
103 | (7) |
|
|
110 | (3) |
|
Bleeding and vascular complications |
|
|
113 | (1) |
|
Adjunctive rotational atherectomy |
|
|
114 | (1) |
|
Adjunctive Doppler flow measurement |
|
|
114 | (1) |
|
|
114 | (2) |
|
Stenting compared with surgery |
|
|
116 | (1) |
|
|
117 | (5) |
|
Assessment of the role of intravascular ultrasound (IVUS) |
|
|
122 | (3) |
|
Assessment of the role of high-pressure stent deployment |
|
|
125 | (1) |
|
Comparison of access site |
|
|
125 | (1) |
|
Treatment of in-stent restenosis |
|
|
126 | (1) |
|
Stenting in small vessels |
|
|
127 | (12) |
|
Current Indications for Stenting |
|
|
139 | (58) |
|
Treatment of abrupt or threatened vessel closure during angioplasty |
|
|
140 | (5) |
|
Primary reduction in restenosis in de-novo focal lesions in vessels greater than 3.0 mm in diameter |
|
|
145 | (1) |
|
Saphenous vein graft disease |
|
|
146 | (1) |
|
|
147 | (5) |
|
Acute myocardial infarction |
|
|
152 | (3) |
|
Restenotic lesions after previous balloon angioplasty |
|
|
155 | (2) |
|
Ostial and left main disease |
|
|
157 | (2) |
|
|
159 | (11) |
|
|
170 | (1) |
|
Cardiac allograft vasculopathy |
|
|
170 | (27) |
|
Stent Guidance and Adjunctive Approaches |
|
|
197 | (18) |
|
|
197 | (1) |
|
Role of intravascular ultrasound |
|
|
198 | (5) |
|
|
203 | (1) |
|
|
204 | (1) |
|
|
204 | (11) |
|
Directional coronary atherectomy (DCA) |
|
|
205 | (1) |
|
|
205 | (1) |
|
Transluminal extraction atherectomy (TEC) |
|
|
206 | (1) |
|
Eximer laser coronary angioplasty (ELCA) |
|
|
206 | (9) |
|
Complications of Coronary Stenting |
|
|
215 | (78) |
|
Subacute stent thrombosis |
|
|
215 | (78) |
|
|
215 | (1) |
|
Factors affecting stent thrombosis |
|
|
216 | (4) |
|
Device related (Surface interactions, Rheological factors) Patient-related factors (Vessel characteristics, Haemostatic predictors) |
|
|
220 | (2) |
|
Technique-related factors |
|
|
222 | (4) |
|
|
226 | (7) |
|
|
233 | (1) |
|
|
234 | (1) |
|
|
234 | (3) |
|
|
237 | (3) |
|
|
240 | (7) |
|
|
247 | (3) |
|
Bleeding and vascular injury |
|
|
250 | (1) |
|
|
251 | (1) |
|
|
252 | (1) |
|
|
252 | (1) |
|
|
253 | (1) |
|
|
253 | (1) |
|
Coronary artery aneurysms |
|
|
254 | (39) |
|
|
293 | (4) |
|
|
297 | (4) |
|
|
301 | (2) |
Appendix A List of Abbreviations |
|
303 | (2) |
Appendix B List of Clinical Trials |
|
305 | (2) |
Index |
|
307 | |